Previously published studies have demonstrated the successful use of adenoviral constructs for BDNF overexpression in Alzheimer’s disease [70,71], Huntington’s disease [72], and Friedrich’s motor ataxia [39]. The gene discussed is BDNF; the disease is Huntington disease.